Document is current
Any future updates will be listed below
-
Authors
Svensson, F. https://orcid.org/0000-0002-6630-8820
Felson, D. T.
Turkiewicz, A.
Guermazi, A.
Roemer, F. W.
Neuman, P.
Englund, M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (AG18393, AR47785)
The Swedish Research Council
The Kock Foundation
The Swedish Rheumatism Association
Region Skåne
Governmental Funding of Clinical Research within National Health Service
Medicinska Fakulteten, Lunds Universitet
- License Information
-
More Information
Article History
Received: 28 May 2018
Revised: 24 October 2018
Accepted: 23 November 2018
First Online: 10 January 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Martin Englund.
: The authors of this manuscript declare relationships with the following companies:Dr. Guermazi reports personal fees from MerckSerono, Kolon TissueGene, OrthoTrophix, GE Healthcare, AstraZeneca, Pfizer, and Sanofi and personal fees from Boston Imaging core Lab, LLC, outside the submitted work.Dr. Roemer reports other from Boston Imaging Core Lab. (BICL), LLC, outside the submitted work.Each other author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, and patent/licensing arrangements) that might pose a conflict of interest in connection with the submitted article.
: Aleksandra Turkiewicz provided most of the statistical work for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • cross-sectional study• multicenter study
